Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Understand What I Mean, Not What I Say

    Oct 2, 2017, 10:45 AM by Michael Croft

    Bio-IT World Contributed Commentary | In the field of biobanking, where it is common for biobanks to evolve for different purposes, in disparate locations, and with isolated informatics systems, it’s no surprise that communication within and across biobanks, even within one institution, is challenging and fraught with miscommunications.

    Full story
  • Security Takes On Malicious DNA (Files)

    Sep 29, 2017, 15:20 PM by Michael Croft
    Security Now | Securing biomedical research can mean protecting systems from malicious code in the samples under investigation, University of Washington security researchers say.
    Full story
  • Standardized Interpretation Pipelines Will Be Essential For Genomic Medicine

    Sep 29, 2017, 10:50 AM by Michael Croft

    Bio-IT World Contributed Commentary | Next-generation sequencing continues to offer new hope for scientists and clinicians focused on everything from rare disease to cancer. Still, the clinical application of genomics could use some crucial improvements— perhaps none more urgent than standardized automated tools for genome interpretation.

    Full story
  • The Zika Virus Grew Deadlier With A Small Mutation Study Suggests

    Sep 28, 2017, 15:09 PM by Michael Croft
    The New York Times | A single variation in its DNA may have helped equip the virus to attack fetal cells, contributing to a surge of birth defects in Latin America.
    Full story
  • As Consumer DNA Testing Grows, Two States Resist

    Sep 28, 2017, 14:46 PM by Michael Croft
    MIT Technology Review | Maryland and New York still restrict who can order genetic tests and how companies can market them.
    Full story
  • Celgene’s Big Data IQ

    Sep 28, 2017, 09:20 AM by Michael Croft

    Bio-IT World | In recent years, Celgene has been doubling down on its information analytics capabilities, and in January it launched an internal big data platform to more cohesively manage data to drive decision-making from pre-clinical research through commercialization.

    Full story
  • Genedata Screener Strengthens Collaborative Research at Axxam

    Sep 27, 2017, 08:36 AM by Michael Croft
    BASEL, SWITZERLAND - Sep 27, 2017 - Genedata, a leading provider of advanced software solutions for R&D, today announced that Axxam has extended its licensing of Genedata Screener® as its collaborative research platform for data analysis of high-throughput screening, compound profiling, and safety screening campaigns
    Full story
  • Adam Rutherford to speak at Lab Innovations 2017

    Sep 26, 2017, 11:24 AM by Michael Croft
    , ENGLAND - Sep 26, 2017 - Lab Innovations – the UK’s only dedicated showcase for laboratory, analytical and biotech equipment – returns to the NEC, Birmingham, for its sixth consecutive year on the 1st and 2nd of November 2017
    Full story
  • SIRION Biotech and Vibalogics partner to offer complete Adeno-Associated Virus (AAV) services

    Sep 26, 2017, 11:17 AM by Michael Croft
    - Sep 26, 2017 - Munich, Germany - SIRION Biotech GmbH and Vibalogics GmbH, have signed a strategic partnership agreement designed to meet demand from gene therapy companies for a start-to-finish Adeno-Associated Virus (AAV) service
    Full story
  • The drug-makers guide to the galaxy

    Sep 26, 2017, 10:40 AM by Michael Croft
    Nature News & Comment | How machine learning and big data are helping chemists search the vast chemical universe for better medicines.
    Full story
  • Quanticate reinforces global offering with new Indian office

    Sep 26, 2017, 07:32 AM by Michael Croft
    BANGALORE, INDIA - Sep 26, 2017 - Quanticate, a global data-focused clinical research organisation (CRO), is further expanding its service offering into India with the opening of a new office
    Full story
  • StemExpress Signs Distribution Agreement with CliniSciences

    Sep 25, 2017, 17:31 PM by Michael Croft
    FOLSOM, CA - Sep 26, 2017 - StemExpress is a premier provider of human blood-derived cell products, including bone marrow, cord blood, peripheral blood, Leukopaks®, Mobilized Leukopaks, and primary cells
    Full story
  • Deep Genomics Raises $13 Million To Develop Genetic Medicines

    Sep 25, 2017, 16:10 PM by Michael Croft

    Bio-IT World Brief | Deep Genomics received a USD $13 million equity investment led by Khosla Ventures. They are accompanied by early stage investment firm True Ventures. In the next three years, Deep Genomics will use its platform to unlock new classes of anti-sense oligonucleotide therapies that were previously inaccessible, and advance them for clinical evaluation.

    Full story
  • Congenica, PerkinElmer, Illumina, And More: News From September 2017

    Sep 25, 2017, 14:15 PM by Michael Croft

    Bio-IT World | September featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Congenica, PerkinElmer, Illumina, and more.

    Full story
  • Jackson Lab Files Federal Complaint, Accusing Chinese University Of Selling Its Mice

    Sep 22, 2017, 13:30 PM by Michael Croft

    Hartford Courant | The Jackson Laboratory is suing to stop Nanjing University, whom it accuses of selling offspring of the genomics center’s mice used for research.

    Full story
  • BioIVT Expands its Support of the Annual North American ISSX Meeting; Highlights Advances in Drug Metabolism and Toxicology Research

    Sep 21, 2017, 12:43 PM by Michael Croft
    WESTBURY, NY - Sep 21, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it is increasing its support of the annual North American International Society for the Study of Xenobiotics (ISSX) Meeting
    Full story
  • Even At $500K, Gene Therapy Could Be A Bargain For Some Diseases

    Sep 21, 2017, 08:53 AM by Michael Croft
    MIT Technology Review | A one-time gene therapy that costs half a million dollars sounds crazy until you add up what it costs to treat some diseases over a lifetime.
    Full story
  • ABL acquisition extends Ardena’s early-phase offering

    Sep 21, 2017, 05:38 AM by Michael Croft
    - Sep 21, 2017 - Early-phase contract development and manufacturing organisation (CDMO), Ardena, has acquired bioanalytical contract laboratory, Analytical Biochemical Laboratory (ABL)
    Full story
  • MDI Biological Laboratory Study Finds Immune System Is Critical to Regeneration

    Sep 20, 2017, 15:30 PM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Sep 20, 2017 - The answer to regenerative medicine’s most compelling question -- why some organisms can regenerate major body parts such as hearts and limbs while others, such as humans, cannot -- may lie with the body’s innate immune system, according to a new study of heart regeneration in the axolotl, or Mexican salamander, an organism that takes the prize as nature’s champion of regeneration
    Full story
  • CRISPR Used To Peer Into Human Embryo's First Days

    Sep 20, 2017, 13:38 PM by Michael Croft
    Nature News & Comment | Gene-edited embryos enable researchers to unpick role of a crucial gene, with more studies likely to follow.
    Full story
  • «
  • 291
  • 292
  • 293 (current)
  • 294
  • 295
  • 296
  • 297
  • 298
  • 299
  • 300
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy